Hemoperfusion Combined with Hemofiltration versus Hemofiltration Alone in Acute Organophosphorus Poisoning: A Propensity-Matched Cohort Study
Journal of Visualized Experiments · 2026-11-10 · (237)
DOI: 10.3791/74443 ↗At a glance
Kohortenstudie in Journal of Visualized Experiments, published online on 2026-11-10. Written by Jin-Song Xia and 3 co-authors.
Abstract (original language)
Acute organophosphate pesticide poisoning (AOPP) is associated with systemic inflammation, oxidative stress, cholinergic dysfunction, and life-threatening complications. This retrospective cohort study compared hemoperfusion combined with hemofiltration (HP+HF) versus hemofiltration (HF) alone in 204 patients admitted to the First People's Hospital of Daishan County between January and December 2024. After 1:1 propensity score matching using a caliper of 0.2 standard deviations of the logit propensity score, 102 patients were included in each group. Both groups received routine treatment, with HP+HF additionally provided to the observation group. Outcomes included clinical efficacy, cholinesterase (CHE), dopamine (DA), liver function, inflammatory and oxidative stress markers, and in-hospital complications. After treatment, the HP+HF group showed significantly higher CHE, DA, and superoxide dismutase (SOD) levels and significantly lower aspartate aminotransferase (AST), alanine aminotransferase (ALT), transforming growth factor beta 1 (TGF-β1), tumor necrosis factor alpha (TNF-α), interleukin 6 (IL-6), and lipid peroxide (LPO) levels than the HF group on days 1 and 7 (P < 0.05). The total clinical effective rate was significantly higher with HP+HF than with HF alone (93.1% vs. 78.4%, P = 0.005). The incidences of respiratory failure, intermediate syndrome, pulmonary infection, and kidney injury were significantly lower in the HP+HF group (all P < 0.05). In fully adjusted multivariable logistic regression, HP+HF was associated with higher odds of clinical effectiveness (adjusted OR = 3.921, 95% CI: 1.543-9.963, P = 0.004) and lower odds of complications (adjusted OR = 0.246, 95% CI: 0.134-0.451, P < 0.001) compared with HF alone. These findings suggest that HP+HF was associated with better clinical and biochemical outcomes and fewer complications than HF alone in patients with AOPP.
Cite
APA
Xia, J., Wang, W., Fu, J., & Zhang, Z. (2026). Hemoperfusion Combined with Hemofiltration versus Hemofiltration Alone in Acute Organophosphorus Poisoning: A Propensity-Matched Cohort Study. Journal of Visualized Experiments. https://doi.org/10.3791/74443
Vancouver
Xia J, Wang W, Fu J, Zhang Z. Hemoperfusion Combined with Hemofiltration versus Hemofiltration Alone in Acute Organophosphorus Poisoning: A Propensity-Matched Cohort Study. Journal of Visualized Experiments. 2026. doi:10.3791/74443
BibTeX
@article{Xia2026,
author = {Xia, Jin-Song and Wang, Wei-Jie and Fu, Jing and Zhang, Zheng-Li},
title = {Hemoperfusion Combined with Hemofiltration versus Hemofiltration Alone in Acute Organophosphorus Poisoning: A Propensity-Matched Cohort Study},
journal = {Journal of Visualized Experiments},
year = {2026},
number = {237},
doi = {10.3791/74443}
}
EUVIMED